Am. J. Respir. Crit. Care Med., Volume 162, Number 4, October 2000, 1445-1449

Prospective Randomized Comparison of Thoracoscopic Talc Poudrage under Local Anesthesia versus Bleomycin Instillation for Pleurodesis in Malignant Pleural Effusions

ANDREAS H. DIACON, CHRISTOPH WYSER, CHRISTOPH T. BOLLIGER, MICHAEL TAMM, MIKLOS PLESS, ANDRÉ P. PERRUCHOUD, and MARKUS SOLÈR

Department of Internal Medicine, University Hospital, Basel, Switzerland

Induction of pleurodesis offers benefit for patients with metastatic tumors and symptomatic malignant pleural effusions, but the best method for achieving this is still unknown. In this prospective, randomized comparison of two well-established pleurodesis procedures, 36 patients with malignant pleural effusions, expanded lungs after drainage, and expected survival of > 1 mo received either bleomycin instillation (60E) via a small-bore thoracostomy tube or thoracoscopic talc poudrage (5 g) under local anesthesia. Efficacy, safety, and cost could be evaluated for 32 treatments (17 bleomycin, 15 talc) in 31 patients. Recurrence rates of effusion with bleomycin and talc poudrage after 30 d were 41% and 13% (p = 0.12), respectively, those after 90 d were 59% and 13%, respectively (p = 0.01), and those after 180 d were 65% and 13% (p = 0.005), respectively. Neither procedure showed any major adverse effect, and both were equally well tolerated. Cost estimation favored thoracoscopic talc poudrage, both for the initial hospitalization and with regard to recurrences. In conclusion, thoracoscopic talc pleurodesis under local anesthesia is superior to bleomycin instillation for pleurodesis in cases of malignant pleural effusion.

This article has been cited by other articles:

				D. Feller-Kopman, M. J. Parker, and R. M. Schwartzstein Assessment of Pleural Pressure in the Evaluation of Pleural Effusions Chest, January 1, 2009; 135(1): 201 - 209. [Full Text] [PDF]

				A. Tremblay, C. Mason, and G. Michaud Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis Eur. Respir. J., October 1, 2007; 30(4): 759 - 762. [Abstract] [Full Text] [PDF]

				A. R. Haas, D. H. Sterman, and A. I. Musani Malignant Pleural Effusions: Management Options With Consideration of Coding, Billing, and a Decision Approach Chest, September 1, 2007; 132(3): 1036 - 1041. [Abstract] [Full Text] [PDF]

				P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF]

				V. Steger, U. Mika, H. Toomes, T. Walker, C. Engel, T. Kyriss, G. Ziemer, and G. Friedel Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses Ann. Thorac. Surg., June 1, 2007; 83(6): 1940 - 1945. [Abstract] [Full Text] [PDF]

				T. F. Molnar and R. Rami-Porta Some reflections on talc poudrage Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1147 - 1147. [Full Text] [PDF]

				A. Stefani, P. Natali, C. Casali, and U. Morandi Talc poudrage versus talc slurry in the treatment of malignant pleural effusion.: A prospective comparative study Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 827 - 832. [Abstract] [Full Text] [PDF]

				C. Tan, A. Sedrakyan, J. Browne, S. Swift, and T. Treasure The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 829 - 838. [Abstract] [Full Text] [PDF]

				A. L. Akopov, V. I. Egorov, V. V. Varlamov, Y. N. Levashev, and D. Y. Artioukh Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 750 - 753. [Abstract] [Full Text] [PDF]

				O. Dikensoy, Z. Zhu, E. Donnelly, G. T. Stathopoulos, K. B. Lane, and R. W. Light Combination Therapy With Intrapleural Doxycycline and Talc in Reduced Doses Is Effective in Producing Pleurodesis in Rabbits Chest, November 1, 2005; 128(5): 3735 - 3742. [Abstract] [Full Text] [PDF]

				S. Kolschmann, A. Ballin, and A. Gillissen Clinical Efficacy and Safety of Thoracoscopic Talc Pleurodesis in Malignant Pleural Effusions Chest, September 1, 2005; 128(3): 1431 - 1435. [Abstract] [Full Text] [PDF]

				C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al. Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion Chest, March 1, 2005; 127(3): 909 - 915. [Abstract] [Full Text] [PDF]

				Y. C. G. Lee, M. H. Baumann, N. A. Maskell, G. W. Waterer, T. E. Eaton, R. J. O. Davies, J. E. Heffner, and R. W. Light Pleurodesis Practice for Malignant Pleural Effusions in Five English-Speaking Countries: Survey of Pulmonologists Chest, December 1, 2003; 124(6): 2229 - 2238. [Abstract] [Full Text] [PDF]

				A. Bernard, R. B. de Dompsure, O. Hagry, and J. P. Favre Early and late mortality after pleurodesis for malignant pleural effusion Ann. Thorac. Surg., July 1, 2002; 74(1): 213 - 217. [Abstract] [Full Text] [PDF]

				E. M. Marom, J. J. Erasmus, J. E. Herndon II, C. Zhang, and H. P. McAdams Usefulness of Imaging-Guided Catheter Drainage and Talc Sclerotherapy in Patients with Metastatic Gynecologic Malignancies and Symptomatic Pleural Effusions Am. J. Roentgenol., July 1, 2002; 179(1): 105 - 108. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804. [Full Text] [PDF]